Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness

Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness

Abstract Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.

Bibliographic Details
Main Authors: Tommaso Accinni, Marianna Frascarelli, Francesco Ghezzi, Alessia Panzera, Antonino Buzzanca, Martina Fanella, Carlo Di Bonaventura, Luca Carlone, Nicoletta Girardi, Massimo Pasquini, Fabio Di Fabio
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Clinical Case Reports
Subjects:
genetics
pharmacology
psychiatry
Online Access:https://doi.org/10.1002/ccr3.4134
id doaj-b777327f82ea44f69459d6ac68a07f15
record_format Article
spelling doaj-b777327f82ea44f69459d6ac68a07f152021-06-04T10:35:50ZengWileyClinical Case Reports2050-09042021-05-0195n/an/a10.1002/ccr3.4134Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectivenessTommaso Accinni0Marianna Frascarelli1Francesco Ghezzi2Alessia Panzera3Antonino Buzzanca4Martina Fanella5Carlo Di Bonaventura6Luca Carlone7Nicoletta Girardi8Massimo Pasquini9Fabio Di Fabio10Department of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyDepartment of Human Neurosciences Sapienza University Rome ItalyAbstract Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.https://doi.org/10.1002/ccr3.4134geneticspharmacologypsychiatry
collection DOAJ
language English
format Article
sources DOAJ
author Tommaso Accinni
Marianna Frascarelli
Francesco Ghezzi
Alessia Panzera
Antonino Buzzanca
Martina Fanella
Carlo Di Bonaventura
Luca Carlone
Nicoletta Girardi
Massimo Pasquini
Fabio Di Fabio
spellingShingle Tommaso Accinni
Marianna Frascarelli
Francesco Ghezzi
Alessia Panzera
Antonino Buzzanca
Martina Fanella
Carlo Di Bonaventura
Luca Carlone
Nicoletta Girardi
Massimo Pasquini
Fabio Di Fabio
Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
Clinical Case Reports
genetics
pharmacology
psychiatry
author_facet Tommaso Accinni
Marianna Frascarelli
Francesco Ghezzi
Alessia Panzera
Antonino Buzzanca
Martina Fanella
Carlo Di Bonaventura
Luca Carlone
Nicoletta Girardi
Massimo Pasquini
Fabio Di Fabio
author_sort Tommaso Accinni
title Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
title_short Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
title_full Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
title_fullStr Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
title_full_unstemmed Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
title_sort clozapine‐induced gastroesophageal rumination in 22q11.2 deletion syndrome. a case report on gastroesophageal side effects management without renouncing clozapine's effectiveness
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-05-01
description Abstract Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.
topic genetics
pharmacology
psychiatry
url https://doi.org/10.1002/ccr3.4134
work_keys_str_mv AT tommasoaccinni clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT mariannafrascarelli clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT francescoghezzi clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT alessiapanzera clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT antoninobuzzanca clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT martinafanella clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT carlodibonaventura clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT lucacarlone clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT nicolettagirardi clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT massimopasquini clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
AT fabiodifabio clozapineinducedgastroesophagealruminationin22q112deletionsyndromeacasereportongastroesophagealsideeffectsmanagementwithoutrenouncingclozapineseffectiveness
_version_ 1721397512581939200

Similar Items